In addition, it is possible to speculate that in vivo, colonic tumor cells acquire the ability to produce MMP regulatory factors other than CXCL12, such as mutations in tumor suppressor genes or proto-oncogenes, changes in the microenvironment, extracellular matrix composition, tissue oxygenation and inflammation [227]. The gene discussed is CXCL12; the disease is neoplasm.